In individuals with type 2 diabetes, the increasing insulin requirements, owing to insulin resistance or excess β-cell stimulation by sulfonylurea, result in β-cell overload with impaired processing of IP into insulin and C-peptide [8,9]. The gene discussed is INS; the disease is type 2 diabetes mellitus.